Innova Captab IPO Details
Issue Date
21 Jan - 26 Jan'24
Price Range
₹426 - ₹448
Lot Size
33
IPO Size
₹570.00 Cr
Innova Captab IPO Listing Details
Listing On
29 Dec'23
Issue Price
₹448
Listed Price
₹ 452.1
Retail Gain/Listing Gain
▲0.92%
Schedule of Innova Captab IPO
Start date
21/01/2024
End date
26/01/2024
Allotment of bids
Refund Initiation
Listing on exchange
29/12/2023
Company Background
Innova Captab Limited is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain, including research and development, manufacturing, drug distribution, marketing and exports.
The business comprises three main components: (i) a contract development and manufacturing organisation (CDMO) offering manufacturing services to Indian pharmaceutical companies, (ii) a domestic branded generics business, and (iii) an international branded generics business.
Let's take a look at the competitive strengths and risk factors for Innova Captab Limited:
Competitive Strengths
Leading presence and one of the fastest-growing CDMOs in the Indian pharmaceutical formulations market
The number of CDMO products sold has grown by 131.43% from 1,066 in Fiscal 2021 to 2,467 in Fiscal 2023, on a restated consolidated basis. The number of CDMO products sold in the three months ended June 30, 2023, was 1,088 on a restated consolidated basis. To maintain its market position, the company is continuously expanding its portfolio.
Well-established relationships with a marquee CDMO customer base
The company has developed strong relationships across the Indian pharmaceutical industry. In Fiscal 2023, it had 182 CDMO customers. Some of their key customers include Cipla Limited, Glenmark Pharmaceuticals Limited, and Wockhardt Limited, among many other notable brands.
Consistent financial performance
The company has demonstrated strong growth in terms of revenues and profitability. In Fiscal 2022, among Indian formulation CDMO players, they company recorded the third-highest operating revenue, the second-highest operating profit margin and the third-highest net profit margin (Source: CRISIL Report, October 2023).
Risk Factors
- The company operates in a highly competitive market
- The company has recently acquired Sharon, and does not yet know whether it will achieve the expected benefits from such an acquisition.
- The business is dependent and will continue to depend on its manufacturing facilities, and are subject to certain risks such as the breakdown or failure of equipment.
Key Strategies
- Expansion of their manufacturing capacities.
- Integration of the acquired Sharon business.
- Expand the wallet share of existing customers and develop new customers.
Innova Captab Ltd Key Financials
Here are the key financials for Innova Captab Limited:
How to apply for IPO through ASBA
Kotak Securities
•00m 59 s
How To Apply for Innova Captab Ltd IPO?
Here are the steps to apply for Innova Captab Ltd IPO:
Step 1: Log in to your Kotak Securities Demat account Log in to your Demat account to access IPO investments. Next, select the current IPO section.
Step 2: Specify IPO details Enter the number of lots and the price you wish to apply for.
Step 3: Enter UPI ID After entering your UPI ID, click submit. This will place your bid with the exchange.
Step 4: Mandate Notification Your UPI app will receive a mandate notification to block funds.
Step 5: Approve Request Your funds will be blocked once you approve the mandate request on your UPI.
Trending IPOs
07 Jan - 09 Jan'26 | |||||||||
09 Jan - 13 Jan'26 | |||||||||
09 Jan - 13 Jan'26 | |||||||||
13 Jan - 16 Jan'26 | |||||||||
13 Jan - 16 Jan'26 | |||||||||
Innova Captab IPO FAQs
Trending IPOs
07 Jan - 09 Jan'26 | |||||||||
09 Jan - 13 Jan'26 | |||||||||
09 Jan - 13 Jan'26 | |||||||||
13 Jan - 16 Jan'26 | |||||||||
13 Jan - 16 Jan'26 | |||||||||